H. Minami

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

Jun Yu Li, E. Baba, E. Van Cutsem, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer.

T. Yoshino, M. Tahara, T. Doi, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer

K. Nibu, N. Kiyota, N. Otsuki, 2020, International Journal of Clinical Oncology.

Open-Label Phase II Study of the Efficacy of Nivolumab for Cancer of Unknown Primary.

K. Yonemori, Y. Iwamoto, J. Tanizaki, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

J. Tabernero, A. Grothey, S. Kopetz, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

E. Baba, E. Van Cutsem, F. Lordick, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

Y. Hasegawa, M. Tsukuda, M. Fujii, 2011, Cancer Chemotherapy and Pharmacology.